3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Radiation Fibrosis Syndrome
2
Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
1
Pancreatic Neoplasms
1
Pancreatic Ductal Adenocarcinoma
1
Pancreatic Adenocarcinoma
1
Inflammation
1
Fibrosis
1
Fallopian Tube Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Camurati-Engelmann Syndrome
1
Interventions
Bevacizumab
39
atezolizumab
26
durvalumab
24
Nivolumab
21
lenvatinib
20
tremelimumab
16
Specimen Handling
16
Magnetic Resonance Spectroscopy
13
sintilimab
11
pembrolizumab
11
Ipilimumab
10
tislelizumab
7
X-Rays
7
Sorafenib
7
Immunoglobulin G
7
regorafenib
6
Disulfides
6
Cyclophosphamide
6
cabozantinib
5
Radiotherapy
5
Radiosurgery
5
Blood Specimen Collection
5
Radiation
4
Oxaliplatin
4
Immunotherapy
4
Fluorouracil
4
Ethiodized Oil
4
Biopsy
4
fludarabine
3
donafenib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Hepatocellular
×
Losartan
×
90 days
×
Clear all
No trials found.